GSC The List

Post Reply
Forum Home > I > INFLAMMATION* (2014-2015)

[email protected]
Site Owner
Posts: 1174

The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full – 2014)

Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction (full – 2014)

Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia (full – 2014)

A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full – 2014)

Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium (full – 2014)

CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full – 2014)

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full – 2014)

Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function (full – 2014)

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full – 2014)

Endocannabinoids and inflammatory response in periodontal ligament cells (full – 2014)

Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full – 2014)

Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full– 2014)

The endocannabinoid system: an emerging key player in inflammation. (abst – 2014)

Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst – 2014)

Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst – 2014)

Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity (abst – 2014)

Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst – 2014)

Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014)

Host Neuro- Immuno-Endocrine Responses In Periodontal Disease (abst – 2014)

Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation (abst – 2014)

Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation (abst – 2014)

Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst – 2014)

Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (abst – 2014)

Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst – 2014)

Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst – 2014)

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst – 2014)

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (abst – 2014)

Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (abst – 2014)

Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014)

Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (abst – 2014)

Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst – 2014)

Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst – 2014)

Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload (abst – 2014)

Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst – 2014)

Increased oxidative stress enhances endocannabinoid tone (abst – 2014)

Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (abst – 2014)

Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain (abst – 2014)

The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst – 2014)

Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst – 2014)

Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent (abst – 2014)

Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst – 2014)

Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (abst – 2014)

Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors (abst – 2014)

Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment (abst – 2014)

Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (abst – 2014)

The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells (abst – 2014)

Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques (abst – 2014)

N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N palmitoylethanolamine levels and counteracts murine colitis (abst – 2014)

Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury (abst – 2014)

Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways (abst – 2014)

Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst – 2014)

Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst – 2014)

Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis (abst – 2014)

Neuroinflammation as a possible link between cannabinoids and addiction (abst – 2014)

The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst – 2014)

Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (abst – 2014)

Potential applications of marijuana and cannabinoids in medicine (abst – 2014)

COX-2-derived endocannabinoid metabolites as novel inflammatory mediators (abst – 2014)

Enhanced microglial activity in FAAH-/- animals (abst – 2014)

Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease (abst – 2014)

Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation (abst – 2014)

Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst – 2014)

Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain (abst – 2014)

Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (abst – 2014)

Drugs Related to Cannabis Have Pain-Relieving Potential for Osteoarthritis (news – 2014)

Study uncovers marijuana's potential to treat autoimmune diseases (news – 2014)

Synthetic cannabinoid molecule created for osteoarthritis (news – 2014)

Pot Smokers Show Less Inflammation (news – 2014)

The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full – 2015)

Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells (full – 2015)

Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full – 2015)

Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis (abst – 2015)

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. (abst – 2015)

March 16, 2015 at 2:19 AM Flag Quote & Reply

This topic is closed, no additional posts are allowed.